Your Mark On The World

Glioblastoma (GBM) is the most complex and aggressive type of cancer that originates in the brain. There hasn’t been a new FDA approved treatment brought to market in 15 years, and survival rates for GBM have not changed in 30 years - 90% of those diagnosed succumbing to the disease within five years. For the 1.4 million people worldwide living with malignant brain tumors, and an estimated 256,000 that will be diagnosed by the end of the year, this is a grim reality. Venturing where others have not, the Ivy Brain Tumor Center is taking a completely different approach to personalized care with industry-first clinical trials that are based on: Advanced genetic testing that matches each patient with the best possible treatment. Micro-dosing, which reduces short-term side effects. The combining of FDA approved treatments for GBM with other FDA approved cancer drugs that have never-before been used for brain tumors. As a result, the Ivy Brain Tumor Center can now determine if any given course of treatment is w